FDA Approves CHILDRENS MOTRIN — Kenvue Brands LLC
Kenvue Brands LLC noted today that the U.S. Food and Drug Administration recognizes Children’s Motrin (ibuprofen oral solution) as stable for up to 70 months, a critical label update that contracts shelf life exposure for pharmacy inventory but bolsters long-term product safety standards for the manufacturer.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day